ABECMA Trademark

Trademark Overview

On Wednesday, August 14, 2019, a trademark application was filed for ABECMA with the United States Patent and Trademark Office. The USPTO has given the ABECMA trademark a serial number of 88578888. The federal status of this trademark filing is REGISTERED as of Tuesday, August 16, 2022. This trademark is owned by Celgene Corporation. The ABECMA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for use in the treatment of multiple myeloma, cancer, diseases in the fields of oncology; pharmaceutical preparations, namely, cytokine inhibitory drugs
abecma

General Information

Serial Number88578888
Word MarkABECMA
Filing DateWednesday, August 14, 2019
Status700 - REGISTERED
Status DateTuesday, August 16, 2022
Registration Number6821504
Registration DateTuesday, August 16, 2022
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, October 22, 2019

Trademark Statements

Description of MarkThe mark consists of "ABECMA" in red font with a hummingbird design to the left and above the "A" with its head in light blue and its wings fluttering quickly with the colors red, light blue, green and light and dark purple.
Goods and ServicesPharmaceutical preparations for use in the treatment of multiple myeloma, cancer, diseases in the fields of oncology; pharmaceutical preparations, namely, cytokine inhibitory drugs
Indication of Colors claimedThe color(s) red, green, light blue, and light and dark purple is/are claimed as a feature of the mark.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, August 29, 2019
Primary Code005
First Use Anywhere DateFriday, March 26, 2021
First Use In Commerce DateFriday, March 26, 2021

Trademark Owner History

Party NameCelgene Corporation
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901
Party NameCelgene Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901
Party NameCelgene Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901

Trademark Events

Event DateEvent Description
Tuesday, August 16, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, August 16, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, July 12, 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Sunday, July 10, 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, June 2, 2022STATEMENT OF USE PROCESSING COMPLETE
Thursday, May 26, 2022USE AMENDMENT FILED
Thursday, May 26, 2022TEAS STATEMENT OF USE RECEIVED
Tuesday, December 14, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, December 10, 2021SOU EXTENSION 4 GRANTED
Friday, December 10, 2021SOU EXTENSION 4 FILED
Friday, December 10, 2021TEAS EXTENSION RECEIVED
Friday, June 18, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 16, 2021SOU EXTENSION 3 GRANTED
Wednesday, June 16, 2021SOU EXTENSION 3 FILED
Wednesday, June 16, 2021TEAS EXTENSION RECEIVED
Monday, June 14, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, June 9, 2021TEAS POST PUBLICATION AMENDMENT RECEIVED
Saturday, December 19, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 17, 2020SOU EXTENSION 2 GRANTED
Thursday, December 17, 2020SOU EXTENSION 2 FILED
Thursday, December 17, 2020TEAS EXTENSION RECEIVED
Monday, December 14, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, December 14, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, December 14, 2020TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, December 14, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, December 14, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, December 14, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, September 2, 2020AMENDMENT AFTER NOA NOT ENTERED
Thursday, October 22, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, September 2, 2020TEAS POST PUBLICATION AMENDMENT RECEIVED
Friday, April 17, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 15, 2020SOU EXTENSION 1 GRANTED
Wednesday, April 15, 2020SOU EXTENSION 1 FILED
Wednesday, April 15, 2020TEAS EXTENSION RECEIVED
Tuesday, December 17, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 22, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 22, 2019PUBLISHED FOR OPPOSITION
Wednesday, October 2, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, September 12, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, September 9, 2019ASSIGNED TO EXAMINER
Friday, August 30, 2019NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, August 29, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, August 17, 2019NEW APPLICATION ENTERED IN TRAM

Related Keywords

abecma pharmaceutical preparations namely cytokine inhibitory drugs oncology diseases treatment multiple